11 June 2025
Bike Week 2025: Pedalling towards health – for us and the planet
During Bike Week (9-15 June), Bedfordshire, Luton and Milton Keynes Integrated Care Board (ICB) is encouraging residents to take to two wheels – for better…
Alzheimer’s disease drug, lecanemab
Home »
An NHS spokesperson said:
“The NHS now awaits a final decision from the National Institute for Health and Care Excellence that will look at the clinical benefits and cost-effectiveness of lecanemab and determine if it should be routinely offered by the NHS in England.
“Lecanemab is the first disease modifying treatment for Alzheimer’s disease with a market approval in the UK, and to ensure the health system is prepared for future advances in treatments, a dedicated NHS team is also looking ahead to 27 other drugs which are currently in advanced clinical trials that could be potentially approved by 2030.”
View all news
Latest news and highlights
News
9 June 2025
Men’s Health Week 2025: early diagnosis saves lives
As Men’s Health Week (9-15 June) commences, Bedfordshire, Luton and Milton Keynes Integrated Care Board (ICB) is urging men to prioritise their health by seeking…
News
6 June 2025
Local general practices offering 16% more appointments than last year
The number of appointments available at general practices in Bedfordshire, Luton and Milton Keynes has risen again, according to new figures released by NHS England. The data – covering January…
Case Study
4 June 2025
Digital care records help local care provider to deliver safer, better and…
In September 2024, Sembia Johnson joined M&C Home Support Limited, Bedfordshire as Registered Manager. With 19 staff and 24 clients, the company has been growing steadily since husband-and-wife team Marco…
News
2 June 2025
Celebrating Volunteers’ Week: building trust and stronger communities
As part of Volunteers’ Week (2-8 June 2025), Bedfordshire, Luton and Milton Keynes Integrated Care Board (ICB) is celebrating the vital role volunteers play in supporting health and care across…
News
29 May 2025
More than half a million Pharmacy First consultations provide fast access to…
More than 600,000 consultations have taken place in the East of England since the launch of the Pharmacy First service last year, enabling people to receive fast treatment from high…